Nalaganje...
Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19
Preexisting hypertension is a known risk factor for severe COVID-19. Abnormal activation of RAS upregulates angiotensin II (Ang-II) and contributes to severe manifestations of COVID-19. Although RAS inhibitors (RASi) are a mainstay of antihypertensive therapy, they have been associated (in some anim...
Shranjeno v:
| izdano v: | Med Hypotheses |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier Ltd.
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8114589/ https://ncbi.nlm.nih.gov/pubmed/34048987 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mehy.2021.110609 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|